CN108383786A - (S) -1- (4- methoxy-benzyls) -1,2,3,4,5,6,7,8- octahydro isoquinolin the preparation methods - Google Patents

(S) -1- (4- methoxy-benzyls) -1,2,3,4,5,6,7,8- octahydro isoquinolin the preparation methods Download PDF

Info

Publication number
CN108383786A
CN108383786A CN201810407931.1A CN201810407931A CN108383786A CN 108383786 A CN108383786 A CN 108383786A CN 201810407931 A CN201810407931 A CN 201810407931A CN 108383786 A CN108383786 A CN 108383786A
Authority
CN
China
Prior art keywords
methoxy
benzyls
isoquinolin
octahydro
octahydro isoquinolin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810407931.1A
Other languages
Chinese (zh)
Inventor
王巧纯
化浩杰
高彰运
蔡畅
龙中柱
蔡水洪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QIDONG DONGYUE PHARMACY CO Ltd
East China University of Science and Technology
Original Assignee
QIDONG DONGYUE PHARMACY CO Ltd
East China University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QIDONG DONGYUE PHARMACY CO Ltd, East China University of Science and Technology filed Critical QIDONG DONGYUE PHARMACY CO Ltd
Priority to CN201810407931.1A priority Critical patent/CN108383786A/en
Publication of CN108383786A publication Critical patent/CN108383786A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals
    • C07D217/20Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

The invention discloses a kind of preparation methods of 1,2,3,4,5,6,7,8 octahydro isoquinolin of dextromethorphan intermediate (S) 1 (4 methoxy-benzyl), with 1 (4 methoxy-benzyl) 3,4,5,6,7,8 hexahydro isoquinolin(II)For raw material, selection plus hydrogen obtain (S) 1 (4 methoxy-benzyl) 1,2 under the conditions of 2 sulfenamide of organic chiral ligand (R) N (5 fluorine, 2 hydroxybenzyl) 2 methylpropane and trichlorosilane, 3,4,5,6,7,8 octahydro isoquinolin(I).The present invention uses organic chiral ligand, raw material cheap, safe, simple and easy to get;Reaction temperature is 20 ~ 15 DEG C, can be realized in the industrial production;Product ee values are up to 63%.

Description

(S) -1- (4- methoxy-benzyls) -1,2,3,4,5,6,7,8- octahydro isoquinolin systems Standby method
Technical field
The present invention relates to a kind of field of pharmaceutical chemistry technology, and in particular to dextromethorphan key intermediate (S) -1- (4- first Oxy-benzyl) -1,2,3,4,5,6,7,8- octahydro isoquinolin synthetic method.
Background technology
(S) -1- (4- methoxy-benzyls) -1,2,3,4,5,6,7,8- octahydros isoquinolin (I) is synthesis maincenter class antitussive The key intermediate of dextromethorphan.This drug has the characteristics that efficient, safety, tolerance are good, additive relatively low, is a kind of be suitble to The antibechic class drug that long-term use or high dose use.Therefore, (S) -1- (4- methoxy-benzyls) -1,2,3,4,5,6,7,8- The improvement of octahydro isoquinolin synthesis technology has very important significance to the production cost for reducing dextromethorphan.
The synthesis technology of tradition (S) -1- (4- methoxy-benzyls) -1,2,3,4,5,6,7,8- octahydro isoquinolin is flat using R- Peach acid carries out the method that chiral resolution obtains single optically-active product.This method the biggest problems are that yield can only close to 50%, Cause a large amount of wastage of material.(S)-O- tertiary butyl valerian ammonia alcohol bases are introduced on the nitrogen-atoms of octahydro isoquinolin in addition, also having Group carries out asymmetric Benzylation method, and carries out asymmetry using chiral ruthenium catalyst under then being acted on by butyl lithium The method of hydrogenating reduction synthesizes -1,2,3,4,5,6,7,8- octahydro isoquinolin of (S) -1- (4- methoxy-benzyls), but due to anti- It answers that condition is harsher or catalyst is more expensive, thus is limited to laboratory synthesis.
Invention content
The purpose of the present invention is to provide a kind of reaction condition is mild, easy to operate, high (S) -1- (the 4- first of product ee values Oxy-benzyl) -1,2,3,4,5,6,7,8- octahydro isoquinolin preparation methods.
Technical solution of the invention is:
A kind of system of dextromethorphan intermediate (S) -1- (4- methoxy-benzyls) -1,2,3,4,5,6,7,8- octahydro isoquinolin Preparation Method, it is characterized in that:The specific steps are:It is original with 1- (4- methoxy-benzyls) -3,4,5,6,7,8- hexahydros isoquinolin (II) Material, in organic chiral ligand (R)-N- (the fluoro- 2- hydroxybenzyls of 5-) -2- methylpropane -2- sulfenamides and trichlorosilane condition Lower selection plus hydrogen obtain (S) -1- (4- methoxy-benzyls) -1,2,3,4,5,6,7,8- octahydros isoquinolin (I).
Reaction temperature is -20 to -15 DEG C.Using dichloromethane as reaction dissolvent.
Its synthetic route is as follows:
Advantage of the present invention:
Using organic chiral ligand, raw material is cheap, safe, simple and easy to get;Reaction temperature is -20~-15 DEG C, can be in work It is realized in industry production;Product ee values are up to 63%.
With reference to embodiment, the invention will be further described.
Specific implementation mode
Embodiment 1:1- (4- methoxy-benzyls) -3,4,5,6,7,8- hexahydro isoquinolin is added in 100mL three-necked flasks (1.28g, 5mmol), (R)-N- (the fluoro- 2- hydroxybenzyls of 5-) -2- methylpropane -2- sulfenamides (0.13g, 0.5mmol) and 20mL steams dichloromethane again, is cooled to -20 DEG C of stirrings under nitrogen protection.Be slowly added dropwise later trichlorosilane (1.35g, 10mmol) enter reaction solution, maintains the temperature at -20 to -15 DEG C of ranges, drip off within 0.5 hour, maintain the temperature at -15 DEG C and continue to stir Mix reaction.Saturated sodium bicarbonate solution is slowly added to after 12h until bubble-free generation, continues to filter after stirring 0.5h.Filtrate point Water phase is extracted twice using 20mL dichloromethane after liquid, is merged organic phase, solvent is removed under reduced pressure after anhydrous sodium sulfate drying, slightly Product obtains 1.15g yellow oils, yield 89.1%, ee values 4% after silica gel column chromatography.
1H NMR(400MHz,CDCl3,ppm)δ:7.07 (d, 2H), 6.78 (d, 2H), 3.72 (s, 3H), 3.18 (d, 1H), 2.93(m,2H),2.64(m,1H),2.40(m,1H),2.10(m,1H),1.99-1.38(m,10H)
Embodiment 2:1- (4- methoxy-benzyls) -3,4,5,6,7,8- hexahydro isoquinolin is added in 100mL three-necked flasks (1.28g, 5mmol), (R)-N- (the fluoro- 2- hydroxybenzyls of 5-) -2- methylpropane -2- sulfenamides (0.25g, 1mmol) and 20mL steams dichloromethane again, is cooled to -20 DEG C of stirrings under nitrogen protection.Be slowly added dropwise later trichlorosilane (1.35g, 10mmol) enter reaction solution, maintains the temperature at -20 to -15 DEG C of ranges, drip off within 0.5 hour, maintain the temperature at -15 DEG C and continue to stir Mix reaction.Saturated sodium bicarbonate solution is slowly added to after 12h until bubble-free generation, continues to filter after stirring 0.5h.Filtrate point Water phase is extracted twice with 20mL dichloromethane again after liquid, merges organic phase, solvent is removed under reduced pressure after anhydrous sodium sulfate drying.Make 1.12g yellow oils, yield 86.8%, ee values 31% are obtained after crossing column with silica gel.
1H NMR(400MHz,CDCl3,ppm)δ:7.07 (d, 2H), 6.78 (d, 2H), 3.72 (s, 3H), 3.18 (d, 1H), 2.93(m,2H),2.64(m,1H),2.40(m,1H),2.10(m,1H),1.99-1.38(m,10H)。
Embodiment 3:1- (4- methoxy-benzyls) -3,4,5,6,7,8- hexahydro isoquinolin is added in 100mL three-necked flasks (1.28g, 5mmol), (R)-N- (the fluoro- 2- hydroxybenzyls of 5-) -2- methylpropane -2- sulfenamides (0.50g, 2mmol) and 20mL steams dichloromethane again, is cooled to -20 DEG C of stirrings under nitrogen protection.Be slowly added dropwise later trichlorosilane (1.35g, 10mmol) enter reaction solution, maintains the temperature at -20 to -15 DEG C of ranges, drip off within 0.5 hour, maintain the temperature at -15 DEG C and continue to stir Mix reaction.Saturated sodium bicarbonate solution is slowly added to after 12h until bubble-free generation, continues to filter after stirring 0.5h.Filtrate point Water phase is extracted twice using 20mL dichloromethane after liquid, is merged organic phase, solvent is removed under reduced pressure after anhydrous sodium sulfate drying, slightly Product obtains 1.14g yellow oils, yield 88.4%, ee values 63% after silica gel column chromatography.
1H NMR(400MHz,CDCl3,ppm)δ:7.07 (d, 2H), 6.78 (d, 2H), 3.72 (s, 3H), 3.18 (d, 1H), 2.93(m,2H),2.64(m,1H),2.40(m,1H),2.10(m,1H),1.99-1.38(m,10H)。

Claims (3)

1. a kind of preparation of dextromethorphan intermediate (S) -1- (4- methoxy-benzyls) -1,2,3,4,5,6,7,8- octahydro isoquinolin Method, it is characterized in that:The specific steps are:With 1- (4- methoxy-benzyls) -3,4,5,6,7,8- hexahydro isoquinolin(II)For raw material, It is selected under the conditions of organic chiral ligand (R)-N- (the fluoro- 2- hydroxybenzyls of 5-) -2- methylpropane -2- sulfenamides and trichlorosilane It selects plus hydrogen obtains (S) -1- (4- methoxy-benzyls) -1,2,3,4,5,6,7,8- octahydro isoquinolin(I).
2. dextromethorphan intermediate (S) -1- (4- methoxy-benzyls) -1,2,3,4,5,6,7,8- according to claim 1 The preparation method of octahydro isoquinolin, it is characterized in that:Reaction temperature is -20 to -15 DEG C.
3. dextromethorphan intermediate (S) -1- (4- methoxy-benzyls) -1,2,3,4,5,6,7 according to claim 1 or 2, The preparation method of 8- octahydro isoquinolin, it is characterized in that:Using dichloromethane as reaction dissolvent.
CN201810407931.1A 2018-05-02 2018-05-02 (S) -1- (4- methoxy-benzyls) -1,2,3,4,5,6,7,8- octahydro isoquinolin the preparation methods Pending CN108383786A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810407931.1A CN108383786A (en) 2018-05-02 2018-05-02 (S) -1- (4- methoxy-benzyls) -1,2,3,4,5,6,7,8- octahydro isoquinolin the preparation methods

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810407931.1A CN108383786A (en) 2018-05-02 2018-05-02 (S) -1- (4- methoxy-benzyls) -1,2,3,4,5,6,7,8- octahydro isoquinolin the preparation methods

Publications (1)

Publication Number Publication Date
CN108383786A true CN108383786A (en) 2018-08-10

Family

ID=63066015

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810407931.1A Pending CN108383786A (en) 2018-05-02 2018-05-02 (S) -1- (4- methoxy-benzyls) -1,2,3,4,5,6,7,8- octahydro isoquinolin the preparation methods

Country Status (1)

Country Link
CN (1) CN108383786A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110643650A (en) * 2019-09-20 2020-01-03 复旦大学 Preparation method of (S) -1-benzyl-1, 2,3,4,5,6,7, 8-octahydroisoquinoline compound

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1927830A (en) * 2006-10-24 2007-03-14 中国科学院成都生物研究所 Compound of optically pure sulfenamides and application thereof
CN104119273A (en) * 2014-04-24 2014-10-29 上海天慈生物谷生物工程有限公司 Novel method for preparing dextromethorphan

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1927830A (en) * 2006-10-24 2007-03-14 中国科学院成都生物研究所 Compound of optically pure sulfenamides and application thereof
CN104119273A (en) * 2014-04-24 2014-10-29 上海天慈生物谷生物工程有限公司 Novel method for preparing dextromethorphan

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DONG PEI ET AL.: "S-Chiral Sulfinmides as highly enantioselectives organocatalysts", 《ORG. LETT.》 *
GAKU HATTORI ET AL.: "Copper-catalyzed Asymmetric propargylic substitution reactions of propargylic acetates with amines", 《ANGEW. CHEM. INT. ED.》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110643650A (en) * 2019-09-20 2020-01-03 复旦大学 Preparation method of (S) -1-benzyl-1, 2,3,4,5,6,7, 8-octahydroisoquinoline compound
CN110643650B (en) * 2019-09-20 2023-03-07 复旦大学 Preparation method of (S) -1-benzyl-1, 2,3,4,5,6,7, 8-octahydroisoquinoline compound

Similar Documents

Publication Publication Date Title
CN103044317B (en) The method and system of preparation 3-picoline
CN108383786A (en) (S) -1- (4- methoxy-benzyls) -1,2,3,4,5,6,7,8- octahydro isoquinolin the preparation methods
CN103450018B (en) Preparation method of ethyl acetoacetate
CN102617455B (en) Preparation method of pyridoxal or pyridoxal hydrochloride
CN104774174A (en) Asymmetric synthesis method of S-carbinoxamine
CN106938995A (en) A kind of method of asymmetric synthesis of opthalmological bepotastine besilate
CN101880270A (en) Method for preparing 1,1-cyclopropanedimethyl cyclicsulfite
CN108640892A (en) A kind of synthetic method of 5 hydroxymethyl furfural
CN103450017A (en) Preparation method of methyl acetoacetate
CN106831549B (en) A kind of method of asymmetric synthesis of Claritin carbinoxamine
CN110437201A (en) A kind of composite absorber and its method for ethylene oxide absorption conversion coupled cogeneration ethylene carbonate
CN102119165A (en) Chiral iridium aqua complex and method for producing optically active hydroxy compound using the same
CN104646058B (en) Copper-containing complex catalyst and preparation method and application thereof
CN103551144B (en) Bimetallic composite catalyst for preparing afloqualone and method for preparing afloqualone
CN103553943A (en) Method for preparing para amino phenol by virtue of nitrobenzene hydrogenation
CN103896826A (en) Asymmetric synthesis method of nitrogen protected (3R,4R)-3-methylamino-4-methylpiperidine, and relevant intermediate and raw material preparation method
CN104803829B (en) A kind of method of asymmetric syntheses chirality diarylcarbinols
CN109422648B (en) Continuous extractive distillation separation method of dimethyl carbonate and methanol azeotrope
CN109824600B (en) Method for synthesizing chiral cyclic urea by palladium-catalyzed asymmetric hydrogenation of 2-hydroxypyrimidine compound
Zhang et al. Iridium (III)‐Catalyzed Directed ortho‐C (sp2)–H Amidation of Arenes with Sulfonamides
CN105017189B (en) A kind of synthetic method of fused rings ketone compounds
CN102584674B (en) Preparation method of indole amino acid derivative
CN103772177A (en) Preparation method of p-methoxyacetophenone
CN104788415A (en) Method for asymmetrically synthesizing 4-nitromethyl-3-benzyl-3,4-dihydrocoumarin derivative
CN108101740A (en) A kind of method that fragrance alkynes one kettle way is directly translated into chiral alcohol

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20180810

RJ01 Rejection of invention patent application after publication